These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 39075460)

  • 1. Facilitating the use of the target product profile in academic research: a systematic review.
    Ibnidris A; Liaskos N; Eldem E; Gunn A; Streffer J; Gold M; Rea M; Teipel S; Gardiol A; Boccardi M
    J Transl Med; 2024 Jul; 22(1):693. PubMed ID: 39075460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target Product Profiles for medical tests: a systematic review of current methods.
    Cocco P; Ayaz-Shah A; Messenger MP; West RM; Shinkins B
    BMC Med; 2020 May; 18(1):119. PubMed ID: 32389127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target product profiles for neonatal care devices: systematic development and outcomes with NEST360 and UNICEF.
    Kirby RP; Molyneux EM; Dube Q; McWhorter C; Bradley BD; Gartley M; Oden ZM; Richards-Kortum R; Werdenberg-Hall J; Kumara D; Liaghati-Mobarhan S; Heenan M; Bond M; Ezeaka C; Salim N; Irimu G; Palamountain KM;
    BMC Pediatr; 2023 Nov; 23(Suppl 2):564. PubMed ID: 37968603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target Product Profile for a Machine Learning-Automated Retinal Imaging Analysis Software for Use in English Diabetic Eye Screening: Protocol for a Mixed Methods Study.
    Macdonald T; Dinnes J; Maniatopoulos G; Taylor-Phillips S; Shinkins B; Hogg J; Dunbar JK; Solebo AL; Sutton H; Attwood J; Pogose M; Given-Wilson R; Greaves F; Macrae C; Pearson R; Bamford D; Tufail A; Liu X; Denniston AK
    JMIR Res Protoc; 2024 Mar; 13():e50568. PubMed ID: 38536234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert guidance on target product profile development for AMR diagnostic tests.
    Bachmann TT; Mitsakakis K; Hays JP; van Belkum A; Russom A; Luedke G; Simonsen GS; Abel G; Peter H; Goossens H; Moran-Gilad J; Vila J; Becker K; Moons P; Sampath R; Peeling RW; Luz S; van Staa T; Di Gregori V;
    BMJ Glob Health; 2023 Dec; 8(12):. PubMed ID: 38114235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matching diagnostics development to clinical need: Target product profile development for a point of care test for community-acquired lower respiratory tract infection.
    Gal M; Francis NA; Hood K; Villacian J; Goossens H; Watkins A; Butler CC;
    PLoS One; 2018; 13(8):e0200531. PubMed ID: 30067760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile.
    Ivanova Reipold E; Easterbrook P; Trianni A; Panneer N; Krakower D; Ongarello S; Roberts T; Miller V; Denkinger C
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):707. PubMed ID: 29143620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostics to support elimination of lymphatic filariasis-Development of two target product profiles.
    Won KY; Gass K; Biamonte M; Dagne DA; Ducker C; Hanna C; Hoerauf A; Lammie PJ; Njenga SM; Noordin R; Ramaiah KD; Ramzy R; Scholte RGC; Solomon AW; Souza AA; Tappero J; Toubali E; Weil GJ; Williams SA; King JD
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009968. PubMed ID: 34780503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Early Economic Evaluation into Target Product Profile development for medical tests: advantages and potential applications.
    Cocco P; Messenger MP; Smith AF; West RM; Shinkins B
    Int J Technol Assess Health Care; 2021 Jun; 37(1):e68. PubMed ID: 34096483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target product profiles for novel medicines to prevent and treat preeclampsia: An expert consensus.
    Mcdougall AR; Tuttle A; Goldstein M; Ammerdorffer A; Gülmezoglu AM; Vogel JP
    PLOS Glob Public Health; 2022; 2(11):e0001260. PubMed ID: 36962694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, development, and use of conversational agents in rehabilitation for adults with brain-related neurological conditions: a scoping review.
    Hocking J; Oster C; Maeder A; Lange B
    JBI Evid Synth; 2023 Feb; 21(2):326-372. PubMed ID: 35976047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of summer programmes on the outcomes of disadvantaged or 'at risk' young people: A systematic review.
    Muir D; Orlando C; Newton B
    Campbell Syst Rev; 2024 Jun; 20(2):e1406. PubMed ID: 38873396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile.
    Wang T; McAuslane N; Goettsch WG; Leufkens HGM; De Bruin ML
    Front Pharmacol; 2022; 13():948161. PubMed ID: 35924050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.